Melatonin
•Last Updated: February 1 2023
Melatonin is a hormone secreted in the brain that regulates sleep. It appears to be highly sensitive to Light Therapy and Dark Therapy. Oral ingestion of melatonin may be used as a sleep aid. It is non-addictive.
Melatonin is most often used for
Last Updated: February 1 2023
Melatonin is a neurohormone secreted by the pineal gland in the brain and it is well known for causing and regulating sleep. Light suppresses melatonin synthesis. The primary use of melatonin as a supplement is to normalize abnormal sleep patterns.
Irregular sleep patterns are associated with a wide variety of health problems and premature aging. Melatonin is the hormone used by your body to help you fall asleep, and thus supplementation is seen as a way to get regular sleep. This is particularly useful for people who engage in shift work or are jet lagged.
Melatonin may also have general neuroprotective effects, related to its antioxidant effects. Melatonin also has several anti-cancer properties, and is currently being investigated for its role in fighting breast cancer, although human studies on the topic are lacking.
Melatonin does not appear to have much of an effect on lean mass or body fat, but potentially stops your body from gaining more fat. Melatonin supplementation also benefits gastric (stomach) health, possibly reduces tinnitus, and improve mood (by helping you get better sleep).
There are some demographics that tend to have irregular melatonin production in their body. Smokers tend to be less responsive to supplementation, and older people tend to not produce as much during night time. Depression has also been associated with lower melatonin levels.
In typical dosages, melatonin appears fairly safe. Side effects are both uncommon and usually mild, including daytime sleepiness, headache, and nausea. Very rarely, serious adverse effects resulting from melatonin supplementation (often in very high doses) have been reported.
Taking melatonin is not associated with negative feedback (when taking supplementation causes your body to produce less of a hormone). It is also not addictive.
Melatonin’s primary mechanism is by helping decrease the time it takes to fall asleep (as a hormone, that's its primary job).
Note that Melatonin is also known as:
- N-Acetyl-5-Methoxytryptamine
- Melatonine
- Melovine
- Melatol
- Melatonex
- Circadin
For regulating the sleep cycle, doses of melatonin between 500mcg (0.5mg) and 5mg seem to work. Start with 500mcg, and if it doesn’t work, work up to 3-5mg. The benefits of melatonin are not dose-dependent - taking more will not help you fall asleep faster.
To help with sleep, take roughly 30 minutes before going to bed.
Growth hormone appears to spike slightly better at 5mg than 500mcg, although both doses are fairly effective.
What works and what doesn't?
Unlock the full potential of Examine
Latest ResearchRead all studies
1.^Hattori A, Migitaka H, Iigo M, Itoh M, Yamamoto K, Ohtani-Kaneko R, Hara M, Suzuki T, Reiter RJIdentification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebratesBiochem Mol Biol Int.(1995 Mar)
2.^Peuhkuri K, Sihvola N, Korpela RDietary factors and fluctuating levels of melatoninFood Nutr Res.(2012)
3.^Tan DX, Hardeland R, Manchester LC, Korkmaz A, Ma S, Rosales-Corral S, Reiter RJFunctional roles of melatonin in plants, and perspectives in nutritional and agricultural scienceJ Exp Bot.(2012 Jan)
4.^Iriti M, Varoni EM, Vitalini SMelatonin in traditional Mediterranean dietsJ Pineal Res.(2010 Sep)
5.^Determination of the melatonin content of different varieties of tomatoes (Lycopersicon esculentum) and strawberries (Fragariaananassa).()
6.^Reiter RJ, Manchester LC, Tan DXMelatonin in walnuts: influence on levels of melatonin and total antioxidant capacity of bloodNutrition.(2005 Sep)
10.^Valtonen M, Niskanen L, Kangas AP, Koskinen TEffect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjectsNord J Psychiatry.(2005)
12.^Maldonado MD, Moreno H, Calvo JRMelatonin present in beer contributes to increase the levels of melatonin and antioxidant capacity of the human serumClin Nutr.(2009 Apr)
13.^Burkhardt S, Tan DX, Manchester LC, Hardeland R, Reiter RJDetection and quantification of the antioxidant melatonin in Montmorency and Balaton tart cherries (Prunus cerasus)J Agric Food Chem.(2001 Oct)
14.^Chen G, Huo Y, Tan DX, Liang Z, Zhang W, Zhang YMelatonin in Chinese medicinal herbsLife Sci.(2003 May 23)
15.^Sanchez-Hidalgo M, Lu Z, Tan DX, Maldonado MD, Reiter RJ, Gregerman RIMelatonin inhibits fatty acid-induced triglyceride accumulation in ROS17/2.8 cells: implications for osteoblast differentiation and osteoporosisAm J Physiol Regul Integr Comp Physiol.(2007 Jun)
16.^Bernard M, Guerlotté J, Grève P, Gréchez-Cassiau A, Iuvone MP, Zatz M, Chong NW, Klein DC, Voisin PMelatonin synthesis pathway: circadian regulation of the genes encoding the key enzymes in the chicken pineal gland and retinaReprod Nutr Dev.(1999 May-Jun)
17.^Localization, Physiological Significance and Possible Clinical Implication of Gastrointestinal Melatonin.()
18.^Bubenik GA, Konturek SJMelatonin and aging: prospects for human treatmentJ Physiol Pharmacol.(2011 Feb)
19.^Kollmann MT, Locher M, Hirche F, Eder K, Meyer HH, Bruckmaier RMEffects of tryptophan supplementation on plasma tryptophan and related hormone levels in heifers and dairy cowsDomest Anim Endocrinol.(2008 Jan)
20.^Herrero MJ, Martínez FJ, Míguez JM, Madrid JAResponse of plasma and gastrointestinal melatonin, plasma cortisol and activity rhythms of European sea bass (Dicentrarchus labrax) to dietary supplementation with tryptophan and melatoninJ Comp Physiol B.(2007 Apr)
21.^Hardeland RMelatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive metabolitesCell Mol Life Sci.(2008 Jul)
23.^Reppert SM, Weaver DR, Ebisawa TCloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responsesNeuron.(1994 Nov)
24.^Matsumoto M, Sack RL, Blood ML, Lewy AJThe amplitude of endogenous melatonin production is not affected by melatonin treatment in humansJ Pineal Res.(1997 Jan)
25.^Wright J, Aldhous M, Franey C, English J, Arendt JThe effects of exogenous melatonin on endocrine function in manClin Endocrinol (Oxf).(1986 Apr)
26.^Arendt J, Bojkowski C, Folkard S, Franey C, Marks V, Minors D, Waterhouse J, Wever RA, Wildgruber C, Wright JSome effects of melatonin and the control of its secretion in humansCiba Found Symp.(1985)
27.^Hack LM, Lockley SW, Arendt J, Skene DJThe effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjectsJ Biol Rhythms.(2003 Oct)
29.^Dijk DJ, Duffy JFCircadian regulation of human sleep and age-related changes in its timing, consolidation and EEG characteristicsAnn Med.(1999 Apr)
30.^Pang SF, Tang F, Tang PLNegative correlation of age and the levels of pineal melatonin, pineal N-acetylserotonin, and serum melatonin in male ratsJ Exp Zool.(1984 Jan)
31.^Waldhauser F, Kovács J, Reiter EAge-related changes in melatonin levels in humans and its potential consequences for sleep disordersExp Gerontol.(1998 Nov-Dec)
32.^Wetterberg L, Bergiannaki JD, Paparrigopoulos T, von Knorring L, Eberhard G, Bratlid T, Yuwiler ANormative melatonin excretion: a multinational studyPsychoneuroendocrinology.(1999 Feb)
33.^Benot S, Goberna R, Reiter RJ, Garcia-Mauriño S, Osuna C, Guerrero JMPhysiological levels of melatonin contribute to the antioxidant capacity of human serumJ Pineal Res.(1999 Aug)
34.^Pandi-Perumal SR, Zisapel N, Srinivasan V, Cardinali DPMelatonin and sleep in aging populationExp Gerontol.(2005 Dec)
35.^Reiter RJThe pineal gland and melatonin in relation to aging: a summary of the theories and of the dataExp Gerontol.(1995 May-Aug)
36.^Nagata C, Nagao Y, Shibuya C, Kashiki Y, Shimizu HAssociation of vegetable intake with urinary 6-sulfatoxymelatonin levelCancer Epidemiol Biomarkers Prev.(2005 May)
37.^Michalsen A, Schlegel F, Rodenbeck A, Lüdtke R, Huether G, Teschler H, Dobos GJEffects of short-term modified fasting on sleep patterns and daytime vigilance in non-obese subjects: results of a pilot studyAnn Nutr Metab.(2003)
38.^Röjdmark S, Rössner S, Wetterberg LEffect of short-term fasting on nocturnal melatonin secretion in obesityMetabolism.(1992 Oct)
39.^Röjdmark S, Wetterberg LShort-term fasting inhibits the nocturnal melatonin secretion in healthy manClin Endocrinol (Oxf).(1989 Apr)
40.^Stokkan KA, Reiter RJ, Vaughan MK, Nonaka KO, Lerchl AEndocrine and metabolic effects of life-long food restriction in ratsActa Endocrinol (Copenh).(1991 Jul)
41.^Beck-Friis J, von Rosen D, Kjellman BF, Ljunggren JG, Wetterberg LMelatonin in relation to body measures, sex, age, season and the use of drugs in patients with major affective disorders and healthy subjectsPsychoneuroendocrinology.(1984)
42.^Tarquini B, Perfetto F, Poli R, Tarquini RDaytime circulating melatonin levels in smokersTumori.(1994 Jun 30)
43.^Ozguner F, Koyu A, Cesur GActive smoking causes oxidative stress and decreases blood melatonin levelsToxicol Ind Health.(2005 Mar)
44.^Ursing C, von Bahr C, Brismar K, Röjdmark SInfluence of cigarette smoking on melatonin levels in manEur J Clin Pharmacol.(2005 May)
45.^Schrenk D, Brockmeier D, Mörike K, Bock KW, Eichelbaum MA distribution study of CYP1A2 phenotypes among smokers and nonsmokers in a cohort of healthy Caucasian volunteersEur J Clin Pharmacol.(1998 Jan)
46.^The Pineal Peptide Preparation, Epithalamin, Slows Aging in Drosophila melanogaster, Mice, and Rats.()
47.^Anisimov VN, Mylnikov SV, Oparina TI, Khavinson VKEffect of melatonin and pineal peptide preparation epithalamin on life span and free radical oxidation in Drosophila melanogasterMech Ageing Dev.(1997 Aug)
48.^Korkushko OV, Khavinson VKh, Shatilo VB, Antonyk-Sheglova IAPeptide geroprotector from the pituitary gland inhibits rapid aging of elderly people: results of 15-year follow-upBull Exp Biol Med.(2011 Jul)
49.^Mixon MB, Lee E, Coleman DE, Berghuis AM, Gilman AG, Sprang SRTertiary and quaternary structural changes in Gi alpha 1 induced by GTP hydrolysisScience.(1995 Nov 10)
50.^Dubocovich ML, Markowska MFunctional MT1 and MT2 melatonin receptors in mammalsEndocrine.(2005 Jul)
51.^Reppert SM, Weaver DR, Godson CMelatonin receptors step into the light: cloning and classification of subtypesTrends Pharmacol Sci.(1996 Mar)
52.^Roca AL, Godson C, Weaver DR, Reppert SMStructure, characterization, and expression of the gene encoding the mouse Mel1a melatonin receptorEndocrinology.(1996 Aug)
53.^Dubocovich ML, Masana MI, Iacob S, Sauri DMMelatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptorNaunyn Schmiedebergs Arch Pharmacol.(1997 Mar)
54.^Slaugenhaupt SA, Roca AL, Liebert CB, Altherr MR, Gusella JF, Reppert SMMapping of the gene for the Mel1a-melatonin receptor to human chromosome 4 (MTNR1A) and mouse chromosome 8 (Mtnr1a)Genomics.(1995 May 20)
55.^Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MIMolecular pharmacology, regulation and function of mammalian melatonin receptorsFront Biosci.(2003 Sep 1)
56.^Masana MI, Dubocovich MLMelatonin receptor signaling: finding the path through the darkSci STKE.(2001 Nov 6)
57.^Popova JS, Dubocovich MLMelatonin receptor-mediated stimulation of phosphoinositide breakdown in chick brain slicesJ Neurochem.(1995 Jan)
58.^Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F, Fauchere JL, Delagrange P, Canet E, Boutin JAIdentification of the melatonin-binding site MT3 as the quinone reductase 2J Biol Chem.(2000 Oct 6)
59.^Nosjean O, Nicolas JP, Klupsch F, Delagrange P, Canet E, Boutin JAComparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2Biochem Pharmacol.(2001 Jun 1)
61.^Becker-André M, Wiesenberg I, Schaeren-Wiemers N, André E, Missbach M, Saurat JH, Carlberg CPineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamilyJ Biol Chem.(1994 Nov 18)
62.^Yasuo S, Yoshimura T, Ebihara S, Korf HWMelatonin transmits photoperiodic signals through the MT1 melatonin receptorJ Neurosci.(2009 Mar 4)
63.^Ishii H, Tanaka N, Kobayashi M, Kato M, Sakuma YGene structures, biochemical characterization and distribution of rat melatonin receptorsJ Physiol Sci.(2009 Jan)
64.^Mühlbauer E, Peschke EEvidence for the expression of both the MT1- and in addition, the MT2-melatonin receptor, in the rat pancreas, islet and beta-cellJ Pineal Res.(2007 Jan)
65.^Kazantzis M, Takahashi V, Hinkle J, Kota S, Zilberfarb V, Issad T, Abdelkarim M, Chouchane L, Strosberg ADPAZ6 cells constitute a representative model for human brown pre-adipocytesFront Endocrinol (Lausanne).(2012)
66.^Reppert SM, Weaver DR, Ebisawa T, Mahle CD, Kolakowski LF JrCloning of a melatonin-related receptor from human pituitaryFEBS Lett.(1996 May 20)
67.^Bechtold DA, Sidibe A, Saer BR, Li J, Hand LE, Ivanova EA, Darras VM, Dam J, Jockers R, Luckman SM, Loudon ASA role for the melatonin-related receptor GPR50 in leptin signaling, adaptive thermogenesis, and torporCurr Biol.(2012 Jan 10)
68.^Sidibe A, Mullier A, Chen P, Baroncini M, Boutin JA, Delagrange P, Prevot V, Jockers RExpression of the orphan GPR50 protein in rodent and human dorsomedial hypothalamus, tanycytes and median eminenceJ Pineal Res.(2010 Apr)
69.^Ivanova EA, Bechtold DA, Dupré SM, Brennand J, Barrett P, Luckman SM, Loudon ASAltered metabolism in the melatonin-related receptor (GPR50) knockout mouseAm J Physiol Endocrinol Metab.(2008 Jan)
71.^Jockers R, Maurice P, Boutin JA, Delagrange PMelatonin receptors, heterodimerization, signal transduction and binding sites: what's newBr J Pharmacol.(2008 Jul)
72.^Levoye A, Dam J, Ayoub MA, Guillaume JL, Couturier C, Delagrange P, Jockers RThe orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerizationEMBO J.(2006 Jul 12)
73.^Mundey K, Benloucif S, Harsanyi K, Dubocovich ML, Zee PCPhase-dependent treatment of delayed sleep phase syndrome with melatoninSleep.(2005 Oct)
75.^Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period.()
76.^Sack RL, Brandes RW, Kendall AR, Lewy AJEntrainment of free-running circadian rhythms by melatonin in blind peopleN Engl J Med.(2000 Oct 12)
77.^Dawson D, Gibbon S, Singh PThe hypothermic effect of melatonin on core body temperature: is more betterJ Pineal Res.(1996 May)
78.^Meeking DR, Wallace JD, Cuneo RC, Forsling M, Russell-Jones DLExercise-induced GH secretion is enhanced by the oral ingestion of melatonin in healthy adult male subjectsEur J Endocrinol.(1999 Jul)
79.^Mero AA, Vähälummukka M, Hulmi JJ, Kallio P, von Wright AEffects of resistance exercise session after oral ingestion of melatonin on physiological and performance responses of adult menEur J Appl Physiol.(2006 Apr)
80.^Cagnacci A, Soldani R, Yen SSMelatonin enhances cortisol levels in aged women: reversible by estrogensJ Pineal Res.(1997 Mar)
81.^Cagnacci A, Elliott JA, Yen SSAmplification of pulsatile LH secretion by exogenous melatonin in womenJ Clin Endocrinol Metab.(1991 Jul)
82.^Waldhauser F, Waldhauser M, Lieberman HR, Deng MH, Lynch HJ, Wurtman RJBioavailability of oral melatonin in humansNeuroendocrinology.(1984 Oct)
83.^Markantonis SL, Tsakalozou E, Paraskeva A, Staikou C, Fassoulaki AMelatonin pharmacokinetics in premenopausal and postmenopausal healthy female volunteersJ Clin Pharmacol.(2008 Feb)
84.^Wetterberg L, Eriksson O, Friberg Y, Vangbo BA simplified radioimmunoassay for melatonin and its application to biological fluids. Preliminary observations on the half-life of plasma melatonin in manClin Chim Acta.(1978 Jun)
85.^Bechgaard E, Lindhardt K, Martinsen LIntranasal absorption of melatonin in vivo bioavailability studyInt J Pharm.(1999 May 10)
86.^Ma X, Idle JR, Krausz KW, Gonzalez FJMetabolism of melatonin by human cytochromes p450Drug Metab Dispos.(2005 Apr)
87.^Facciolá G, Hidestrand M, von Bahr C, Tybring GCytochrome P450 isoforms involved in melatonin metabolism in human liver microsomesEur J Clin Pharmacol.(2001 Mar)
88.^Skene DJ, Papagiannidou E, Hashemi E, Snelling J, Lewis DF, Fernandez M, Ioannides CContribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slicesJ Pineal Res.(2001 Nov)
89.^Ma X, Idle JR, Krausz KW, Gonzalez FJMetabolism of melatonin by human cytochromes p450Drug Metab Dispos.(2005 Apr)
90.^Grözinger M, Härtter S, Wang X, Röschke J, Hiemke C, Rose DMFluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profileArch Gen Psychiatry.(2000 Aug)
91.^Härtter S, Grözinger M, Weigmann H, Röschke J, Hiemke CIncreased bioavailability of oral melatonin after fluvoxamine coadministrationClin Pharmacol Ther.(2000 Jan)
92.^Rimmele U, Spillmann M, Bärtschi C, Wolf OT, Weber CS, Ehlert U, Wirtz PHMelatonin improves memory acquisition under stress independent of stress hormone releasePsychopharmacology (Berl).(2009 Mar)
93.^Arangino S, Cagnacci A, Angiolucci M, Vacca AM, Longu G, Volpe A, Melis GBEffects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy menAm J Cardiol.(1999 May 1)
94.^Nishiyama K, Yasue H, Moriyama Y, Tsunoda R, Ogawa H, Yoshimura M, Kugiyama KAcute effects of melatonin administration on cardiovascular autonomic regulation in healthy menAm Heart J.(2001 May)
95.^Cagnacci A, Arangino S, Angiolucci M, Maschio E, Melis GBInfluences of melatonin administration on the circulation of womenAm J Physiol.(1998 Feb)
96.^Zisapel N, Laudon MDopamine release induced by electrical field stimulation of rat hypothalamus in vitro: inhibition by melatoninBiochem Biophys Res Commun.(1982 Feb 26)
97.^Zisapel N, Egozi Y, Laudon MInhibition of dopamine release by melatonin: regional distribution in the rat brainBrain Res.(1982 Aug 19)